[Disseminated intravascular coagulation. II. Therapeutic problems].
The treatment of DIC often presents problems that are not easily solved given the difficulty of interpreting symptoms and haematological findings, the seriousness of the clinical situation and the rapid development of disease phenomena. Diagnostic questions must be answered before physiopathologically rational therapy can be applied. The identification and cure of the condition which triggers coagulation are also of primary importance in selecting a therapeutic response. Apart from specific treatment of the causal disease, the treatment of DIC is based on the one hand on the use of anticoagulants (heparin) to halt intravascular coagulation and transfusional integration with haemoderivatives and platelet concentrates to correct the haemostasis deficiency secondary to such massive consumption. On the other, direct methods are needed to control the state of shock, cardiorespiratory compromise and acute renal insufficiency which often complicate the course of the defibrination syndrome. Therapeutic success depends on timely intervention allied to the employment of adequate measures for each individual case.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D001002:Anuria / Q000517:prevention & control; D007611:Aprotinin / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001803:Blood Transfusion; D004176:Dipyridamole / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000628:therapy*; D005169:Factor VIII / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D012772:Shock, Septic / Q000628:therapy; D013923:Thromboembolism / Q000517:prevention & control
D000933:Antifibrinolytic Agents; D004176:Dipyridamole; D005169:Factor VIII; D006493:Heparin; D007611:Aprotinin; D001241:Aspirin
La coagulazione intravascolare disseminata II. - problemi terapeutici.